Pacific Biosciences of California PACB Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
Based on trailing twelve months.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's free cash flow yield?
- Pacific Biosciences of California (PACB) reported free cash flow yield of -29.2% in Q1 2026.
- How has Pacific Biosciences of California's free cash flow yield changed year-over-year?
- Pacific Biosciences of California's free cash flow yield increased by 42.5% year-over-year, from -50.7% to -29.2%.
- What is the long-term trend for Pacific Biosciences of California's free cash flow yield?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's free cash flow yield has grown at a 66.9% compound annual growth rate (CAGR), from -2.6% to -20.2%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.